Virus reactivation after immunotherapy of anti-NMDAR encephalitis secondary to herpes simplex encephalitis: A case report

Brain Dev. 2021 Nov;43(10):1057-1060. doi: 10.1016/j.braindev.2021.06.005. Epub 2021 Jul 6.

Abstract

Herpes simplex encephalitis is the most common cause of sporadic fatal encephalitis. More than half of patients with herpes simplex encephalitis will die and the vast majority of survivors have severe neurologic sequelae without effective antiviral therapy. Some people experience relapses such as secondary anti-N-methyl-d-aspartate receptor encephalitis despite appropriate antiviral treatment. It is rare that virus reactivation after immunotherapy of anti-N-methyl-d-aspartate receptor encephalitis after herpes simplex encephalitis. In the present study, we retrospectively review one patient who showed this rare situation.

Keywords: Anti-N-methyl-d-aspartate receptor encephalitis; Herpes simplex encephalitis; Pediatric; Virus reactivation.

Publication types

  • Case Reports

MeSH terms

  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / drug therapy*
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / etiology*
  • Child
  • Encephalitis, Herpes Simplex / chemically induced*
  • Encephalitis, Herpes Simplex / complications*
  • Humans
  • Immunologic Factors / adverse effects*

Substances

  • Immunologic Factors